AMRN Q4 2018 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$77M+43.6% YoY

Gross Profit

$60M77.4% margin

Operating Income

-$32M-41.1% margin

Net Income

-$34M-43.5% margin

EPS (Diluted)

$-2.14

QoQ Revenue Growth

+39.8%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$32M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$386M

Total Liabilities

$233M

Stockholders' Equity

$152M

Cash & Equivalents

$249M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$54M	+43.6%
Gross Profit	$60M	$40M	+47.9%
Operating Income	-$32M	-$7M	-344.2%
Net Income	-$34M	-$22M	-49.9%

Revenue Segments

Product

$77M100%

License

$245,0000%